<DOC>
	<DOCNO>NCT00755443</DOCNO>
	<brief_summary>The purpose study determine whether Sirolimus stent implantation effective reduce neointimal hyperplasia compare Bare metal stent diabetic patient de novo coronary artery stenosis .</brief_summary>
	<brief_title>Sirolimus-Eluting Stent Versus Standard Stent Diabetic</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Diabetic either noninsulin insulindependent ( accord World Health Organization Report ) pharmacologic treatment ( insulin hypoglycaemic agent ) least 1 month , present de novo coronary stenosis 1,2 3 native vessel symptom objective evidence ischemia . Stenoses amenable stent implantation , vessel size small 4.0 mm ( assess visually angiography ) Impaired glucose tolerance without pharmacologic treatment , gestational diabetes transient hyperglycaemia Stenoses locate saphenous bypass , arterial bypass grafting , unprotected leave main involve important side branch ( &gt; 2 mm ) treat procedure Left ventricle ejection fraction &lt; 25 % Prior treatment intracoronary brachytherapy drug elute stent target site Restenotic lesion ; know allergy aspirin , ticlopidine clopidogrel acute coronary syndrome persistent ST elevation &lt; 72 hour and/or CPK twice upper normal limit NonST elevation acute coronary syndrome CPK twice upper normal limit Severe hepatic renal disease ( creatinin clearance &lt; 30 ml/min hepatic enzyme twice upper normal limit ) ; life expectancy &lt; 1 year</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>